Going forward..., page-1232

I'm glad we are complaining about Christmas cards now instead of loans.

I fully agree with @Sector and I'm glad that Ross finally showed the Japanese that there is no need just yet for him to participate in a world-first to "grow a pair" - made of iPS derived MSCs of course.

When talking about the customer/seller relationship here, let's not forget that we get our starting material from FujiFilm Cellular Dynamics, hence both parties are both customer and seller:
do not advertise external links.au/companies/news/135029/cynata-therapeutics-inks-deal-with-cellular-dynamics-international-57667.html

And speaking of "loss of face", how about FUJIFILM telling the Japanese press back in December last year and therefore after receiving the final CSR:
"Fujifilm plans to apply for a clinical trial (clinical trial) for obtaining approval of transplantation medicine by iPS cells from the country in Japan during FY 2018."
https://www.sankei.com/smp/life/news/181220/lif1812200031-s1.html

Their 2018 financial year ended on 31/03/19 - last Sunday.

Just to then letting your customer/seller release a cryptic ASX statement that even Nicolas Cage at his best couldn't have solved (hence a follow up announcement had to be released) - because your lawyers stumbled over some "structural aspects" of a deal that has been collecting dust for over 24 months.

It was a lost battle anyway:
Make a comment at an investor conference (video has gone viral btw, 268 people have watched it already...) within 24 hrs after your shareholders asked for your head, saying FF won't be getting a Christmas card - you are considered to be rude (how dare he being such a Grinch),
Sent them a Christmas card and your shareholders will call you a money waster given our pre-revenue state, loans to directors and the fact that a postcard to Japan costs $2 (not including the cost of the card!).